Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. (Q55044458)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. |
scientific article |
Statements
Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. (English)
1 reference
B I Eriksson
1 reference
O E Dahl
1 reference
N Rosencher
1 reference
A A Kurth
1 reference
C N van Dijk
1 reference
S P Frostick
1 reference
P Kälebo
1 reference
A V Christiansen
1 reference
S Hantel
1 reference
R Hettiarachchi
1 reference
J Schnee
1 reference
H R Büller
1 reference
RE-MODEL Study Group
1 reference
1 November 2007
1 reference
5
1 reference
11
1 reference
2178-2185
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference